Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Methods (San Diego, Calif.)|May 5, 2009
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responsesJudith Del Campo, Caridad Zayas, Belkis Romeu, et al.
Vaccine|July 11, 2006
Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoidJulio A Balboa, Maribel Cuello, Osmir Cabrera, et al.
Vaccine|July 11, 2006
New method for obtaining conjugated vaccinesOsmir Cabrera, Maribel Cuello, Carmen R Soto, et al.
Scandinavian Journal of Infectious Diseases|June 16, 2011
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responsesBelkis Romeu, Elizabeth González, Caridad Zayas, et al.
Canadian Journal of Microbiology|March 2, 2011
Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1Belkis Romeu, Elyzabeth González, Judith Del Campo, et al.
BMC Immunology|March 6, 2013
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup BCaridad Zayas, Domingo González, Reinaldo Acevedo, et al.
The Pediatric Infectious Disease Journal|February 16, 2021
VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of GonorrheaLaura M Reyes Díaz, Miriam de S J B Lastre González, Maribel Cuello, et al.
Pharmacological Research|May 13, 2017
Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in AfricaReinaldo Acevedo, Caridad Zayas, Gunnstein Norheim, et al.
Pageof 2